Dynavax Technologies Corporation (DVAX): Consensus Estimates and Trading Data

In the past 52-week period, shares of Dynavax Technologies Corporation (NASDAQ:DVAX) have moved within the range of $3.70 to $24.45. On the stock’s most recent trading day, the company’s shares ended the regular session at $18.40, which is 24.74% higher than its 52-week high.

Dynavax Technologies Corporation (DVAX) has demonstrated a 20-day simple moving average (SMA) of -5.95%, and a 50-day SMA of -11.69%. This public company’s current market capitalization stands at $1.09 billion.

Analyzing Consensus Estimates, Sales Revenue and Net Income

When thinking about buying shares in a public company, it is useful to gauge the average enthusiasm level of Wall Street analysts for that specific stock. According to the latest data, the consensus recommendation for Dynavax Technologies Corporation (DVAX) is Outperform.

When it comes to quarterly financial results, publicly-traded companies usually post earnings and revenue figures that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Dynavax Technologies Corporation (DVAX) delivered a 75.91% surprise with its net revenue.

Meanwhile, during the same quarter Dynavax Technologies Corporation (DVAX) delivered a -19.49% earnings surprise. Net earnings for the quarter were posted at -$0.38 per share, whereas Wall Street had forecast -$0.47 per share.

Ownership at Dynavax Technologies Corporation (DVAX), According to Most Recent SEC Filings

Investors can gain useful insight on institutional ownership within a public company by taking a look at the organization’s most recent 13F filings. Dynavax Technologies Corporation (DVAX) has 0 billion shares outstanding currently, 70.83% of which belong to institutional investors. Those institutional holdings amount to $0.79 billion.

Additionally, according to the most recent 13F filing from Dynavax Technologies Corporation (DVAX), there were 27 new positions totaling 3,550,228 shares of the company’s stock. There were 18 sold out positions, on the other hand, totaling 4,685,012 shares.

Short, Medium and Long Term Indicators

By looking at a stock’s average trade volume – in the short, medium, and long terms – we can gain a better understanding of investor sentiment and trading activity. Dynavax Technologies Corporation (DVAX) has had a 20-day average volume of 2,393,130 shares, with an average of 60% of short term indicators pointed at Sell.

The stock’s 50-day average volume has been 1,873,348 shares, with an average of 25% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 2,509,240 shares with 33% of long-term indicators pointing to Buy.